Tag Archives: familial hypercholesterolemia

April, 2017

March, 2017

February, 2017

August, 2015

  • 28 August

    FDA Approves Amgen’s PCSK9 Inhibitor Repatha

    The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options. Repatha, the second drug approved in a new class of drugs known as PCSK9 inhibitors, is approved for use in addition to …